| Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson’s disease models A Iannielli, S Bido, L Folladori, A Segnali, C Cancellieri, A Maresca, ... Cell reports 22 (8), 2066-2079, 2018 | 197 | 2018 |
| dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice G Colasante, G Lignani, S Brusco, C Di Berardino, J Carpenter, ... Molecular Therapy 28 (1), 235-253, 2020 | 190 | 2020 |
| Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study E Esposito, P Mariani, L Ravani, C Contado, M Volta, S Bido, M Drechsler, ... European journal of pharmaceutics and biopharmaceutics 80 (2), 306-314, 2012 | 136 | 2012 |
| Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression M Bourdenx, S Dovero, M Engeln, S Bido, MF Bastide, N Dutheil, ... Acta neuropathologica communications 3, 1-15, 2015 | 126 | 2015 |
| AAV-PHP. B-mediated global-scale expression in the mouse nervous system enables GBA1 gene therapy for wide protection from synucleinopathy G Morabito, SG Giannelli, G Ordazzo, S Bido, V Castoldi, M Indrigo, ... Molecular Therapy 25 (12), 2727-2742, 2017 | 120 | 2017 |
| Targeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease NM Urs, S Bido, SM Peterson, TL Daigle, CE Bass, RR Gainetdinov, ... Proceedings of the National Academy of Sciences 112 (19), E2517-E2526, 2015 | 115 | 2015 |
| Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity S Bido, S Muggeo, L Massimino, MJ Marzi, SG Giannelli, E Melacini, ... Nature communications 12 (1), 6237, 2021 | 114 | 2021 |
| Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease S Bido, FN Soria, RZ Fan, E Bezard, K Tieu Scientific reports 7 (1), 7495, 2017 | 114 | 2017 |
| Amantadine attenuates levodopa‐induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels S Bido, M Marti, M Morari Journal of neurochemistry 118 (6), 1043-1055, 2011 | 100 | 2011 |
| In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels F Mela, M Marti, S Bido, MA Cenci, M Morari Neurobiology of disease 45 (1), 573-582, 2012 | 79 | 2012 |
| Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome N Valassina, S Brusco, A Salamone, L Serra, M Luoni, S Giannelli, S Bido, ... Nature communications 13 (1), 161, 2022 | 49 | 2022 |
| Reconstitution of the human nigro-striatal pathway on-a-chip reveals OPA1-dependent mitochondrial defects and loss of dopaminergic synapses A Iannielli, GS Ugolini, C Cordiglieri, S Bido, A Rubio, G Colasante, ... Cell reports 29 (13), 4646-4656. e4, 2019 | 46 | 2019 |
| Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson’s disease: a behavioral and neurochemical study in reserpinized mice M Volta, OS Mabrouk, S Bido, M Marti, M Morari Journal of neurochemistry 115 (6), 1543-1555, 2010 | 31 | 2010 |
| Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease L Arcuri, R Viaro, S Bido, F Longo, M Calcagno, PO Fernagut, NT Zaveri, ... Neurobiology of disease 89, 55-64, 2016 | 27 | 2016 |
| Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden M Biondi, S Tettamanti, S Galimberti, B Cerina, C Tomasoni, R Piazza, ... Blood, The Journal of the American Society of Hematology 141 (21), 2587-2598, 2023 | 21 | 2023 |
| Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesia S Bido, N Solari, M Indrigo, A D'Antoni, R Brambilla, M Morari, S Fasano Annals of Clinical and Translational Neurology 2 (6), 662-678, 2015 | 21 | 2015 |
| Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease F Faivre, MJ Sánchez-Catalán, S Dovero, S Bido, A Joshi, E Bezard, ... Neurobiology of Disease 139, 104818, 2020 | 17 | 2020 |
| Mol Ther. Dec. 6, 2017; 25 (12): 2727-2742 G Morabito, SG Giannelli, G Ordazzo, S Bido, V Castoldi, M Indrigo, ... Epub Aug 10, 2017 | 13 | 2017 |
| D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly P Barroso-Chinea, ML Thiolat, S Bido, A Martinez, E Doudnikoff, ... Neurobiology of disease 78, 77-87, 2015 | 12 | 2015 |
| A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development V Benedetti, F Banfi, M Zaghi, R Moll-Diaz, L Massimino, L Argelich, ... Science advances 8 (31), eabn3986, 2022 | 11 | 2022 |
Vania BroccoliCNR-Institute of Neuroscience-San Raffaele HospitalAdresse e-mail validée de hsr.it
